Management of Suspected CNS Complications Following MMR Vaccination

Clinical Presentation and Management

The American Academy of Pediatrics recommends administering acetaminophen or ibuprofen immediately to control fever, as fever management is critical to reduce the risk of febrile seizures and improve patient comfort 1
Neurological signs from MMR vaccine-strain virus, if they occur at all, manifest acutely within 6-15 days post-vaccination, with a statistically significant clustering on days 8-9 after administration 1
True vaccine-strain measles encephalopathy occurs at approximately 1 case per 2 million doses distributed, vastly lower than the 1 per 1,000 risk with wild-type measles infection 1
The frequency of reported CNS dysfunction after mumps vaccination is not greater than the observed background incidence rate in the general population 2

The Centers for Disease Control and Prevention recommends obtaining CSF for measles-specific antibody testing showing intrathecal synthesis if encephalitis is suspected 1
Report all suspected serious adverse events following MMR vaccination to the Vaccine Adverse Event Reporting System (VAERS) for passive surveillance 1

Wild-type measles causes encephalitis in approximately 1 per 1,000 infected persons, with permanent brain damage possible in survivors 1
The case fatality rate for measles in the United States is 1-2 per 1,000 cases 1
SSPE occurs in approximately 4-11 per 100,000 measles-infected individuals, particularly those infected at young ages, and is invariably fatal 1
Measles vaccination has essentially eliminated SSPE in countries with high vaccination coverage 1

The Advisory Committee on Immunization Practices (ACIP) definitively states that MMR vaccine does not increase the risk for SSPE, regardless of prior measles infection or vaccination history 3, 4
Febrile seizures occur at 1 per 3,000 doses (5-12 days post-vaccination) but do not cause residual neurological disorders and should not be confused with encephalopathy 1, 3